Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review

The prevalence of obesity and diabetes continues to rise in the US. Glucagon-like peptide-1 receptor agonist (GLP-1RA) is an effective treatment option for type 2 diabetes mellitus (T2DM) that promotes weight loss. Common and effective treatment options added to metformin therapy (basal insulin, sul...

Descripción completa

Detalles Bibliográficos
Autores principales: Berlie, Helen, Hurren, Kathryn M, Pinelli, Nicole R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402010/
https://www.ncbi.nlm.nih.gov/pubmed/22826635
http://dx.doi.org/10.2147/DMSO.S27528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402010/
https://www.ncbi.nlm.nih.gov/pubmed/22826635
http://dx.doi.org/10.2147/DMSO.S27528

Ejemplares similares